Clinical Trial Update: A Randomized, Double-blind Clinical Investigation to Evaluate the Use of the Relievion™ Device in Treating Migraine. [NA]

View source ↗

Summary

A randomized, double-blind trial evaluating the Relievion device for migraine has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• Relievion

Snippet

Sponsor: Neurolief Ltd. | Conditions: Migraine | NA | Status: TERMINATED